These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7682308)

  • 1. Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Hamato H
    Neurosci Lett; 1993 Feb; 150(1):71-4. PubMed ID: 7682308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Hamato H
    Neurosci Lett; 1993 Sep; 159(1-2):135-8. PubMed ID: 7505410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on CSF tryptophan metabolism in infantile spasms.
    Yamamoto H
    Pediatr Neurol; 1991; 7(6):411-4. PubMed ID: 1724601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia.
    Tohgi H; Abe T; Takahashi S; Kimura M; Takahashi J; Kikuchi T
    Neurosci Lett; 1992 Jul; 141(1):9-12. PubMed ID: 1508406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson's patients with severe postural instability and gait disorders.
    Iacono RP; Kuniyoshi SM; Ahlman JR; Zimmerman GJ; Maeda G; Pearlstein RD
    J Neural Transm (Vienna); 1997; 104(4-5):451-9. PubMed ID: 9295177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Nozaki Y; Ueno M; Kikuchi T
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):17-26. PubMed ID: 8094960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of tryptophan and its 5-hydroxy metabolites in human cerebrospinal fluid by reversed phase liquid chromatography with electrochemical detection.
    Laakso JT; Koskiniemi ML; Wahlroos O; Härkönen M
    Scand J Clin Lab Invest; 1983 Oct; 43(6):463-72. PubMed ID: 6197747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of tryptophan, 5-hydroxytryptophan, 5-hydroxytryptamine, 5-hydroxyindoleacetic acid, 4-hydroxy-3-methoxyphenylacetic acid and 3-methoxy-4-hydroxyphenylglycol in human cerebrospinal fluid.
    Yi YH; Liao WP; Lu X
    J Chromatogr B Biomed Appl; 1994 Nov; 661(1):143-8. PubMed ID: 7532522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of tryptophan metabolism via serotonin in cerebrospinal fluid of patients with noncommunicating hydrocephalus using a new endoscopic technique.
    Comai S; Longatti P; Perin A; Bertazzo A; Ragazzi E; Costa CV; Allegri G
    J Neurosci Res; 2006 Aug; 84(3):683-91. PubMed ID: 16721766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and 5-hydroxyindoleacetic acid in CSF. Difference in Parkinson's disease and dementia of the Alzheimer's type.
    Volicer L; Direnfeld LK; Freedman M; Albert ML; Langlias PJ; Bird ED
    Arch Neurol; 1985 Feb; 42(2):127-9. PubMed ID: 2579625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole levels in human lumbar and ventricular cerebrospinal fluid and the effect of L-tryptophan administration.
    Koskiniemi M; Laakso J; Kuurne T; Laipio M; Härkönen M
    Acta Neurol Scand; 1985 Feb; 71(2):127-32. PubMed ID: 2580417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations.
    Loeffler DA; LeWitt PA; Juneau PL; Camp DM; DeMaggio AJ; Havaich MK; Milbury PE; Matson WR
    Neurochem Res; 1998 Dec; 23(12):1521-5. PubMed ID: 9821156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid.
    Eccleston D; Ashcroft GW; Moir AT; Parker-Rhodes A; Lutz W; O'Mahoney DP
    J Neurochem; 1968 Sep; 15(9):947-57. PubMed ID: 5303059
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
    Johansson B; Roos BE
    Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients.
    Tohgi H; Abe T; Takahashi S
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):27-34. PubMed ID: 8439390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of tryptophan metabolism via serotonin in ventricular cerebrospinal fluid in HIV-1 infection using a neuroendoscopic technique.
    Longatti P; Perin A; Comai S; Bertazzo A; Rizzo V; Costa CV; Allegri G
    Curr HIV Res; 2007 Mar; 5(2):267-72. PubMed ID: 17346140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
    Widner B; Leblhuber F; Fuchs D
    J Neural Transm (Vienna); 2002 Feb; 109(2):181-9. PubMed ID: 12075858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serotonergic measures in cerebrospinal fluid and blood of subhuman primate.
    Yan D; Urano T; Pietraszek MH; Shimoyama I; Uemura K; Kojima Y; Sakakibara K; Serizawa K; Takada Y; Takada A
    Life Sci; 1993; 52(8):745-9. PubMed ID: 7680408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin metabolite concentrations in cerebrospinal fluid from schizophrenic patients -- relationships to family history.
    Sedvall G
    Adv Exp Med Biol; 1981; 133():719-25. PubMed ID: 6172022
    [No Abstract]   [Full Text] [Related]  

  • 20. 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.
    Lewitt PA; Li J; Lu M; Beach TG; Adler CH; Guo L;
    Mov Disord; 2013 Oct; 28(12):1653-60. PubMed ID: 23873789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.